Participants were randomly assigned to 2 groups. The perioperative treatment group received pembrolizumab 200mg intravenously (IV) every 3 weeks (Q3W) for 2 cycles, as neoadjuvant therapy prior to ...
Cefpodoxime proxetil 100mg, 200mg; tabs. Susceptible mild to moderate infections including acute otitis media, acute bacterial exacerbations of chronic bronchitis, acute maxillary sinusitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback